Javascript must be enabled to continue!
CXCR7 promotes foetal myoblast fusion at muscle fiber tips independently of Myomaker via a ß1integrin-EGFR-dependent mechanism
View through CrossRef
Abstract
Muscle growth must be tightly regulated during development in order to obtain the final muscle shape. Myoblast fusion is a critical step of muscle growth, driving the formation of syncytial myofibers attaching at both ends to tendons. We investigated the role of the CXCR7 chemokine receptor in foetal muscle growth during chicken limb development. We show that CXCR7 displays a regionalized expression at the tips of myofibers close to tendons in foetal limb muscles, which is exclusive to the central location of the fusion gene MYOMAKER (
TMEM8C
in chicken) in foetal muscles. CXCR7 promotes myoblast fusion independently of
TMEM8C
in chicken limb muscles and in foetal myoblast cultures and requires EGF receptor signalling. The CXCR7 ligand, CXCL12, expressed in connective tissue, increases ß1integrin activation at the myotendinous junction and CXCR7 expression at muscle tips, resulting in a fusion promoting effect independent from a direct binding of CXCL12 to CXCR7 receptor. Our results evidence a CXCR7-dependent/TMEM8C-independent fusion mechanism at the myofiber tips that regulates muscle growth at the tendon/muscle interface during foetal myogenesis.
Title: CXCR7 promotes foetal myoblast fusion at muscle fiber tips independently of Myomaker via a ß1integrin-EGFR-dependent mechanism
Description:
Abstract
Muscle growth must be tightly regulated during development in order to obtain the final muscle shape.
Myoblast fusion is a critical step of muscle growth, driving the formation of syncytial myofibers attaching at both ends to tendons.
We investigated the role of the CXCR7 chemokine receptor in foetal muscle growth during chicken limb development.
We show that CXCR7 displays a regionalized expression at the tips of myofibers close to tendons in foetal limb muscles, which is exclusive to the central location of the fusion gene MYOMAKER (
TMEM8C
in chicken) in foetal muscles.
CXCR7 promotes myoblast fusion independently of
TMEM8C
in chicken limb muscles and in foetal myoblast cultures and requires EGF receptor signalling.
The CXCR7 ligand, CXCL12, expressed in connective tissue, increases ß1integrin activation at the myotendinous junction and CXCR7 expression at muscle tips, resulting in a fusion promoting effect independent from a direct binding of CXCL12 to CXCR7 receptor.
Our results evidence a CXCR7-dependent/TMEM8C-independent fusion mechanism at the myofiber tips that regulates muscle growth at the tendon/muscle interface during foetal myogenesis.
Related Results
Abstract 1166: CXCR7-mediated signaling axis regulates breast cancer growth and metastasis by modulating tumor microenvironment
Abstract 1166: CXCR7-mediated signaling axis regulates breast cancer growth and metastasis by modulating tumor microenvironment
Abstract
Chemokine CXCL12 has been shown to bind chemokine receptor CXCR4 and CXCR7. Although extensive studies have been done to elucidate the role of CXCL12/CXCR4 ...
CXCR7: A β-arrestin-biased receptor that potentiates cell migration and recruits β-arrestin2 exclusively through Gβγ subunits and GRK2
CXCR7: A β-arrestin-biased receptor that potentiates cell migration and recruits β-arrestin2 exclusively through Gβγ subunits and GRK2
Abstract
Background
Some chemokine receptors referred to as atypical chemokine receptors (ACKRs) are thought to non-signaling decoys because of their inability to activate...
CXCR7: A β-arrestin-biased receptor that potentiates cell migration and recruits β-arrestin2 exclusively through Gβγ subunits and GRK2
CXCR7: A β-arrestin-biased receptor that potentiates cell migration and recruits β-arrestin2 exclusively through Gβγ subunits and GRK2
Abstract
Background: Some chemokine receptors referred to as atypical chemokine receptors (ACKRs) are thought to non-signaling decoys because of their inability to activate...
Abstract 5463: Development of a novel antibody-maytansinoid conjugate, IMGN289, for the treatment of EGFR-expressing solid tumors.
Abstract 5463: Development of a novel antibody-maytansinoid conjugate, IMGN289, for the treatment of EGFR-expressing solid tumors.
Abstract
EGFR is an attractive target for the treatment of a variety of solid tumors because of its role as a driver oncogene and high level of expression. Four EGFR...
Poster 247: Muscle ERRγ Overexpression Mitigates the Muscle Atrophy after ACL injury
Poster 247: Muscle ERRγ Overexpression Mitigates the Muscle Atrophy after ACL injury
Objectives:
Anterior cruciate ligament (ACL) reconstruction is the 6th most common orthopedic procedure performed in the United States (1,2). There is substanti...
Plasma ctDNA biomarker study in patients with non-small cell lung cancer with EGFR exon 20 insertion mutation treated with sunvozertinib.
Plasma ctDNA biomarker study in patients with non-small cell lung cancer with EGFR exon 20 insertion mutation treated with sunvozertinib.
8563 Background: There are limited reports on biomarker studies of non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) exon 20 insertion mutation (exon...
SOX4 promotes the growth and metastasis of breast cancer
SOX4 promotes the growth and metastasis of breast cancer
Abstract
Purpose
Increasing evidence has shown that the transcription factor SOX4 is closely associated with the development and progression of many malignant tumors. Howe...
ASSA13-303-4 Study of Brain Injuries Induced by Intrauterine Balloon Aortic Valvuloplasty and Protective Evaluation Indomethacin of on Fetal Lamb Model
ASSA13-303-4 Study of Brain Injuries Induced by Intrauterine Balloon Aortic Valvuloplasty and Protective Evaluation Indomethacin of on Fetal Lamb Model
Objective
To investigate the brain injuries induced by intrauterine balloon aortic valvuloplasty (IUBAV) on a foetal lamb model, and to evaluate the effectiveness...

